Singapore markets open in 8 hours 40 minutes

CStone Pharmaceuticals (2616.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.860+0.030 (+3.61%)
At close: 04:09PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
481,072
481,363
243,718
1,038,832
Cost of revenue
218,299
202,985
106,832
241,421
Gross profit
262,773
278,378
136,886
797,411
Operating expenses
Research development
534,305
614,162
1,304,945
1,404,684
Selling general and administrative
329,940
390,476
472,992
228,882
Total operating expenses
1,034,874
1,181,475
1,930,359
1,861,832
Operating income or loss
-772,101
-903,097
-1,793,473
-1,064,421
Interest expense
11,415
8,477
2,242
1,320
Income before tax
-750,335
-902,678
-1,920,100
-1,220,999
Income from continuing operations
-750,335
-902,678
-1,920,100
-1,220,999
Net income
-750,335
-902,678
-1,920,100
-1,220,999
Net income available to common shareholders
-750,335
-902,678
-1,920,100
-1,220,999
Basic EPS
-0.77
-0.77
-1.65
-1.17
Diluted EPS
-0.77
-0.77
-1.65
-1.17
Basic average shares
1,172,839
1,172,839
1,165,209
1,046,032
Diluted average shares
1,172,839
1,172,839
1,165,209
1,046,032